These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 20552225)
41. Phase II Study of Sorafenib Combined with Concurrent Hepatic Arterial Infusion of Oxaliplatin, 5-Fluorouracil and Leucovorin for Unresectable Hepatocellular Carcinoma with Major Portal Vein Thrombosis. He MK; Zou RH; Li QJ; Zhou ZG; Shen JX; Zhang YF; Yu ZS; Xu L; Shi M Cardiovasc Intervent Radiol; 2018 May; 41(5):734-743. PubMed ID: 29327075 [TBL] [Abstract][Full Text] [Related]
42. A multi-institutional phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis. Ikeda M; Okusaka T; Furuse J; Mitsunaga S; Ueno H; Yamaura H; Inaba Y; Takeuchi Y; Satake M; Arai Y Cancer Chemother Pharmacol; 2013 Aug; 72(2):463-70. PubMed ID: 23812005 [TBL] [Abstract][Full Text] [Related]
44. A novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal vein. Ando E; Yamashita F; Tanaka M; Tanikawa K Cancer; 1997 May; 79(10):1890-6. PubMed ID: 9149014 [TBL] [Abstract][Full Text] [Related]
45. Efficacy and Safety of Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma and Child-Pugh Class B: A Retrospective Cohort Study. Ishii M; Itano O; Iwamoto H; Hibi T; Itano S Oncology; 2022; 100(5):278-289. PubMed ID: 35184053 [TBL] [Abstract][Full Text] [Related]
46. A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapy. Shao YY; Liang PC; Wu YM; Huang CC; Huang KW; Cheng JC; Hsu CH; Hsu C; Cheng AL; Lin ZZ Liver Int; 2013 Oct; 33(9):1413-9. PubMed ID: 23714197 [TBL] [Abstract][Full Text] [Related]
47. A randomized comparative study of high-dose and low-dose hepatic arterial infusion chemotherapy for intractable, advanced hepatocellular carcinoma. Woo HY; Bae SH; Park JY; Han KH; Chun HJ; Choi BG; Im HU; Choi JY; Yoon SK; Cheong JY; Cho SW; Jang BK; Hwang JS; Kim SG; Kim YS; Seo YS; Yim HJ; Um SH; Cancer Chemother Pharmacol; 2010 Jan; 65(2):373-82. PubMed ID: 19763572 [TBL] [Abstract][Full Text] [Related]
48. Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial. Hatooka M; Kawaoka T; Aikata H; Inagaki Y; Morio K; Nakahara T; Murakami E; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Awai K; Masaki K; Waki K; Kohno H; Kohno H; Moriya T; Nagaoki Y; Tamura T; Amano H; Katamura Y; Chayama K BMC Cancer; 2018 Jun; 18(1):633. PubMed ID: 29866075 [TBL] [Abstract][Full Text] [Related]
49. Adjuvant hepatic arterial infusional chemotherapy with 5-fluorouracil and cisplatin after curative resection of hepatocellular carcinoma. Kim DY; Ahn SH; Kim SU; Choi SB; Lee KH; Park MS; Park JY; Lee DY; Han KH; Kim KS Oncology; 2011; 81(3-4):184-91. PubMed ID: 22067673 [TBL] [Abstract][Full Text] [Related]
50. Sorafenib Plus Hepatic Arterial Infusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized Trial. Zheng K; Zhu X; Fu S; Cao G; Li WQ; Xu L; Chen H; Wu D; Yang R; Wang K; Liu W; Wang H; Bao Q; Liu M; Hao C; Shen L; Xing B; Wang X Radiology; 2022 May; 303(2):455-464. PubMed ID: 35103539 [TBL] [Abstract][Full Text] [Related]
51. Adjuvant hepatic arterial infusion chemotherapy is beneficial for selective patients with Hepatocellular carcinoma undergoing surgical treatment. Hsiao JH; Tsai CC; Liang TJ; Chiang CL; Liang HL; Chen IS; Chen YC; Chang PM; Chou NH; Wang BW Int J Surg; 2017 Sep; 45():35-41. PubMed ID: 28728985 [TBL] [Abstract][Full Text] [Related]
52. Hepatic Resection Followed by Hepatic Arterial Infusion Chemotherapy for Hepatocellular Carcinoma with Intrahepatic Dissemination. Kuramoto K; Beppu T; Nitta H; Imai K; Masuda T; Miyata T; Koga Y; Kitano Y; Kaida T; Nakagawa S; Okabe H; Hayashi H; Hashimoto D; Yamashita YI; Chikamoto A; Kikuchi K; Baba H Anticancer Res; 2018 Jan; 38(1):525-531. PubMed ID: 29277819 [TBL] [Abstract][Full Text] [Related]
53. Efficiency and safety of hepatic arterial infusion chemotherapy (HAIC) combined with anti-PD1 therapy versus HAIC monotherapy for advanced hepatocellular carcinoma: A multicenter propensity score matching analysis. Li Y; Liu W; Chen J; Chen Y; Guo J; Pang H; Zhang W; An C; Li C Cancer Med; 2024 Jan; 13(1):e6836. PubMed ID: 38196277 [TBL] [Abstract][Full Text] [Related]
54. Efficacy and safety of hepatic arterial infusion chemotherapy combined with lenvatinib and PD-1 inhibitors for advanced hepatocellular carcinoma with macrovascular invasion. Zhang Y; Zhang H; Xu H; Wang Y; Feng L; Yi F World J Surg Oncol; 2024 May; 22(1):122. PubMed ID: 38711095 [TBL] [Abstract][Full Text] [Related]
55. Reduction of Intrahepatic Tumour by Hepatic Arterial Infusion Chemotherapy Prolongs Survival in Hepatocellular Carcinoma. Sung PS; Yang K; Bae SH; Oh JS; Chun HJ; Nam HC; Jang JW; Choi JY; Yoon SK Anticancer Res; 2019 Jul; 39(7):3909-3916. PubMed ID: 31262920 [TBL] [Abstract][Full Text] [Related]
56. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma according to Child-Pugh classification. Miyaki D; Aikata H; Honda Y; Naeshiro N; Nakahara T; Tanaka M; Nagaoki Y; Kawaoka T; Takaki S; Waki K; Hiramatsu A; Takahashi S; Ishikawa M; Kakizawa H; Awai K; Chayama K J Gastroenterol Hepatol; 2012 Dec; 27(12):1850-7. PubMed ID: 23020312 [TBL] [Abstract][Full Text] [Related]
57. IL-28B variant as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy. Terashima T; Honda M; Toyama T; Shimakami T; Shimizu R; Takatori H; Arai K; Kawaguchi K; Kitamura K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Kaneko S J Gastroenterol Hepatol; 2020 Oct; 35(10):1813-1820. PubMed ID: 32180251 [TBL] [Abstract][Full Text] [Related]
58. [Combination Chemotherapy Using Sorafenib and Hepatic Arterial Infusion with a Fine-Powder Formulation of Cisplatin for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis--A Case Report]. Tsukamoto T; Kanazawa A; Shimizu S; Murata A; Sakae M; Kurihara S; Tashima T; Deguchi S; Nakai T; Kawasaki Y; Kioka K Gan To Kagaku Ryoho; 2015 Nov; 42(12):1878-80. PubMed ID: 26805203 [TBL] [Abstract][Full Text] [Related]
59. Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis after Concurrent Chemoradiation Therapy. Han DH; Joo DJ; Kim MS; Choi GH; Choi JS; Park YN; Seong J; Han KH; Kim SI Yonsei Med J; 2016 Sep; 57(5):1276-81. PubMed ID: 27401662 [TBL] [Abstract][Full Text] [Related]
60. Pilot Study of Hepatic Arterial Infusion Chemotherapy with Interferon-beta and 5-fluorouracil: A New Chemotherapy for Patients with Advanced Hepatocellular Carcinoma. Shakado S; Iwata K; Tsuchiya N; Kunimoto H; Yotsumoto K; Fukunaga A; Kuno S; Tanaka T; Sakurai K; Iwashita H; Hirano G; Yokoyama K; Morihara D; Nishizawa S; Takeyama Y; Irie M; Sohda T; Kora S; Yoshimitsu K; Sakisaka S Hepatogastroenterology; 2014 May; 61(131):557-62. PubMed ID: 26176035 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]